$MDIT Medite Cancer Diagnostics, Inc. Insider Trading

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

CIK Number: 0000075439
IRS Number: 364296006
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Trading Symbol: MDIT
Company Address: 414 NORTH ORLEANS STREET SUITE 502 CHICAGO 60610
Phone number: 407-996-9630
Former name: PACIFIC COAST HOLDINGS INC, date of change: 1983-03-03
Former name: BELL NATIONAL CORP, date of change: 1992-07-03
Former name: AMPERSAND MEDICAL CORP, date of change: 1999-05-27
Former name: MOLECULAR DIAGNOSTICS INC, date of change: 2001-10-09
Former name: CytoCore Inc, date of change: 2006-08-15

MEDITE Cancer Diagnostics, Inc. is a medical technology company which engages in cancer diagnostics instruments and consumables for histology and cytology laboratories. The firm specializes in developing, manufacturing, and marketing of molecular biomarkers premium medical devices and consumables for detection, risk assessment and diagnosis of cancer, precancerous conditions, and related diseases. It operates through the following segments: United States, Germany, and Poland. The company was founded in December 1998 and is headquartered in Orlando, FL.

Market Capitalization: $9.57M
Prev close: $0.45
Average Daily Volume: 2,387
Days Low: $0.00
Year Low: $0.26
Year High: $1.11

Medite Cancer Diagnostics, Inc. Latest Insider Transactions

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Oct 23 2018	MDIT	Medite Cancer Diag ...	ABELES JOHN H		Buy	P	0.08	266,667	20,000	1,566,852	1.3 M to 1.6 M (+20.51 %)
Oct 23 2018	MDIT	Medite Cancer Diag ...	ABELES JOHN H		Buy	J	0.00	40,000	0	1,300,185	1.3 M to 1.3 M (+3.17 %)
Oct 19 2018	MDIT	Medite Cancer Diag ...	Lewis William Austin IV		Buy	P	0.08	80,000	6,000	2,213,333	2.1 M to 2.2 M (+3.75 %)
Oct 19 2018	MDIT	Medite Cancer Diag ...	Lewis William Austin IV		Buy	P	0.08	8,973,333	673,000	36,611,163	27.6 M to 36.6 M (+32.47 %)
Jul 30 2018	MDIT	Medite Cancer Diag ...	Lewis William Austin IV		Buy	P	0.08	1,100,000	82,500	29,771,162	28.7 M to 29.8 M (+3.84 %)
Jul 30 2018	MDIT	Medite Cancer Diag ...	Von Rump Stephen L.	CEO / CFO	Buy	P	0.08	133,333	10,000	266,666	133.3 K to 266.7 K (+100.00 %)
Jul 12 2018	MDIT	Medite Cancer Diag ...	Lewis William Austin IV		Buy	P	0.08	400,000	30,000	28,671,162	28.3 M to 28.7 M (+1.41 %)
Jul 12 2018	MDIT	Medite Cancer Diag ...	Lewis William Austin IV		Buy	P	0.08	6,933,333	520,000	28,271,162	21.3 M to 28.3 M (+32.49 %)
Jul 10 2018	MDIT	Medite Cancer Diag ...	ABELES JOHN H		Buy	P	0.08	400,000	30,000	2,608,381	2.2 M to 2.6 M (+18.11 %)
Jul 05 2018	MDIT	Medite Cancer Diag ...	Lewis William Austin IV		Buy	P	0.08	1,333,334	100,000	21,337,830	20 M to 21.3 M (+6.67 %)
Jul 05 2018	MDIT	Medite Cancer Diag ...	Lewis William Austin IV		Buy	P	0.08	8,000,000	600,000	20,004,496	12 M to 20 M (+66.64 %)
May 08 2018	MDIT	Medite Cancer Diag ...	FORTUNOFF GREGORY		Option Exercise	P	0.08	100,000	7,500	100,000
May 08 2018	MDIT	Medite Cancer Diag ...	FORTUNOFF GREGORY		Buy	P	0.75	1,333,334	1,000,001	1,533,334	200 K to 1.5 M (+666.67 %)
Feb 12 2018	MDIT	Medite Cancer Diag ...	Lewis William Austin IV		Option Exercise	A	0.50	600,000	300,000	912,579
Feb 12 2018	MDIT	Medite Cancer Diag ...	Lewis William Austin IV		Option Exercise	P	0.50	312,579	156,290	312,579

View all Medite Cancer Diagnostics, Inc. insider transactions.